GlassScriptPhysician profile
Sruti K Patel
NPI 1750600888
$7,812.93
in general payments reported to CMS, 2019-2025
18 companies · $1,348 in 2025
The $1,348 reported for 2025 was more than what 76% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.87 · 2021: $62.71 · 2022: $194 · 2023: $463 · 2024: $5,731 · 2025: $1,348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,296 · Education: $2,500 · Food and Beverage: $1,747.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,295.62 |
| Education | $2,500.00 |
| Food and Beverage | $1,747.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,768.88 | 2021-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $2,231.16 | 2023-2024 | Gore Enform Preperitoneal Biomaterial, Gore Bio-A Tissue Reinforcement, Gore Synecor Biomaterial |
| Tela Bio, INC. | $196.06 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Guard Medical INC. | $144.40 | 2025 | Npseal |
| Cardiovascular Systems INC. | $97.22 | 2022 | |
| Medtronic, INC. | $66.14 | 2023-2024 | Endurant Iis, Heli-Fx Endoanchor System |
| Boston Scientific Corporation | $49.11 | 2021-2023 | Spyglass Discover |
| Extremity Medical | $48.90 | 2024 | |
| Polynovo North America LLC | $47.98 | 2022 | |
| Acera Surgical, INC. | $26.73 | 2024 | Restrata Wound Matrix |
| Sanara Medtech INC. | $22.07 | 2024 | Celleraterx |
| Lilly USA, LLC | $19.58 | 2023 | Mounjaro |
| Ethicon US, LLC | $16.73 | 2022 | |
| Novo Nordisk INC | $16.72 | 2022 | |
| Smith+Nephew, INC. | $16.35 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.99 | 2023 | Jardiance, Tradjenta |
| Davol INC. | $15.04 | 2022 | |
| Angiodynamics, INC. | $13.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sruti Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.